More collaboration is needed to understand chemo brain fog

04/2/2013 | Scientist, The (free registration)

Researchers are studying the effects of cancer drugs on the brain in an effort to understand and prevent cognitive decline, or "chemo brain." Mouse studies have shown exercise and the antidepressant fluoxetine might slow or reverse cognitive decline, but the studies do not reflect real-world chemotherapy regimens, writes Ellen Walker, a professor of pharmaceutical sciences at Temple University who is researching chemo brain. The scientific community needs to develop more informative models and set standards for cognitive testing to identify at-risk patients and develop preventive therapies, Walker writes.

View Full Article in:

Scientist, The (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
MGR POST MARKET STUDIES - 14000001LK
Abbott
Santa Ana, CA
Senior Financial Analyst - Growing Manager Care Health Org
Fallon Community Health Plan
Worcester, MA
Associate Director, Regulatory Affairs - Promotional Review
Novo Nordisk
Princeton, NJ
Chief Executive Officer
UCare Minnesota
Minneapolis, MN
Program Coordinator/Lecturer for the Regulatory Science program
Johns Hopkins University
Washington, DC